How a cancer therapy #antibody target was developed and taken to the clinic
515H7 mAb, a new monoclonal antibody which blocks SDF-1/CXCR4 signalling for cancer therapy has been explored by Dr Christine Klinguer-Hamour..
Terrapinn is pleased to make available for download a presentation titled "The state of industry sponsored clinical research in Australia" by Deborah Monk, Director of Innovation and Industry Policy, Medicines Australia,..
515H7 mAb, a new monoclonal antibody which blocks SDF-1/CXCR4 signalling for cancer therapy has been explored by Dr Christine Klinguer-Hamour..
Top new results of #antibody therapeutic developments from Dr Janice Reichert Want to understand why some antibodies succeed as therapeutic..
The clinical trials cycle as we all know it, is a long and tedious process with plenty of regulatory and compliance obstacles. Starting from..
If you have been following news on biotech or trials for cancer treatments lately, it is pretty hard to miss CEO Deborah Rathjen and Bionomics...
The biopharmaceutical industry stands at a crossroads with its very future in question. The problem is deep-seated, with its roots coming from..
One of the most important themes that emerge is that pharmaceutical firms need to look at forging serious partnerships in the economic powerhouses..
Download the whitepaper now In the past few years, the pharma market in Venezuela has been growing. They have the highest per capita consumption..
ClinActis Pte Ltd will participate in the BioPharma Asia Convention 2012 which will take place in Singapore from March 19th to March 22nd,..
A Mexican researcher has concluded animal testing and is gearing up for human trials on a drug that could prevent heroin addiction. This vaccine..
© terrapinn holdings ltd. MMX | images courtesy of SXC | terms & conditions | privacy | log in
